GCP
HURA

GSA Capital Partners’s TuHURA Biosciences HURA Stock Holding History

GSA Capital Partners’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Buy
+62,538
New +$76.6K 0.01% 1555

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

GSA Capital Partners's HURA Position: Q1 2026 in Review

GSA Capital Partners opened a new position in TuHURA Biosciences (HURA) in Q1 2026: 62,538 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #1555 among its holdings.

89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • GSA Capital Partners held 62,538 shares of TuHURA Biosciences worth $112K as of Q1 2026.
  • TuHURA Biosciences was a new GSA Capital Partners position in Q1 2026.
  • TuHURA Biosciences made up 0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1555 holding.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.